指南与共识瓣膜外科

机器人效应:二尖瓣修复中手术入路与指南导向伴发疾病管理的关系

The Robot Effect: How Surgical Approach Relates to Guideline-Directed Management of Concomitant Diseases During Mitral Valve Repair.
指南 / 共识 · Ann Thorac Surg · 2026-08-19

基于STS成人心脏外科数据库2015-2024年17,169例退行性二尖瓣反流行二尖瓣修复患者,比较机器人与正中开胸入路。合并房颤或三尖瓣反流者更少接受机器人手术,且机器人组行手术消融、左心耳封堵或三尖瓣修复的几率更低,但围术期结局相似。

要点

  • 合并房颤或三尖瓣反流者选择机器人二尖瓣修复的几率低于正中开胸
  • 机器人组合并房颤者行手术消融或左心耳封堵的几率更低
  • 机器人组合并三尖瓣反流者行三尖瓣修复的几率更低

核心结论

  • 外科医生对合并房颤或三尖瓣反流的患者更倾向选择正中开胸而非机器人二尖瓣修复。
  • 机器人二尖瓣修复时指南导向的房颤和三尖瓣反流管理更不常见。
  • 无论手术入路如何,患者都应获得坚定的指南导向治疗。

研究设计与样本

  • 回顾性队列研究,使用2015至2024年STS成人心脏外科数据库。
  • 纳入因退行性二尖瓣反流行二尖瓣修复、伴或不伴三尖瓣修复、手术消融或左心耳封堵的患者。
  • 比较机器人入路与正中开胸入路,采用多变量逻辑回归评估主要结局。
  • 共纳入17,169例患者,其中正中开胸8,203例,机器人8,966例。

主要发现

  • 合并房颤者3,245例(18.9%),中度及以上三尖瓣反流者2,565例(14.9%)。
  • 合并房颤者接受机器人手术的比值比为0.51(95%CI 0.45-0.58)。
  • 合并三尖瓣反流者接受机器人手术的比值比为0.50(95%CI 0.43-0.58)。
  • 同时合并房颤和三尖瓣反流者接受机器人手术的比值比为0.38(95%CI 0.31-0.47)。
  • 机器人组合并房颤者行手术消融的比值比为0.44(95%CI 0.35-0.55),行左心耳封堵的比值比为0.40(95%CI 0.31-0.52)。

临床怎么用

  • 面对合并房颤或三尖瓣反流的二尖瓣修复患者,不应因选择机器人入路而降低指南导向伴随疾病处理的实施率。
  • 机器人二尖瓣修复术前应系统评估房颤和三尖瓣反流,并计划相应的消融、左心耳封堵或三尖瓣修复。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Candidates for robot-assisted mitral valve repair (R-MVr) sometimes have concomitant atrial fibrillation (AF) or tricuspid valve regurgitation (TR). We investigated the effect of concomitant AF and moderate or greater TR on choice between R-MVr and median sternotomy (MS-MVr) and the effect of surgical approach on guideline-directed management of AF and TR. METHODS: From 2015 to 2024, patients in The Society of Thoracic Surgeons Adult Cardiac Surgery Database who underwent MVr for degenerative mitral regurgitation with or without concomitant tricuspid valve repair (TVr), surgical ablation (SA), or left atrial appendage occlusion (LAAO) by either robotic or sternotomy approach were identified. Multivariable logistic regression was performed to assess our primary outcomes. RESULTS: The study included 17,169 patients (8203 MS-MVr, 8966 R-MVr). Concomitant AF was present in 3245 (18.9%) and moderate or greater TR in 2565 (14.9%). Patients with AF (odds ratio [OR], 0.51 [95% CI, 0.45-0.58]), TR (OR, 0.50 [0.43-0.58]), or both (OR, 0.38 [0.31-0.47]) were less likely to receive R-MVr vs MS-MVr. Compared with MS-MVr, patients undergoing R-MVr with AF less frequently had concomitant SA (OR, 0.44 [0.35-0.55]) or LAAO (OR, 0.40 [0.31-0.52]), and those with TR less frequently had TVr (OR, 0.25 [0.19-0.32]). Operative outcomes were similar between MS-MVr and R-MVr with concomitant SA, LAAO, or TVr. CONCLUSIONS: Surgeons are more likely to perform MS-MVr than R-MVr for patients with AF or TR, whereas guideline-directed management of AF and TR is less common with R-MVr, demonstrating a complex relationship between concomitant conditions and surgical approach. Patients deserve a steadfast commitment to guideline-directed care, irrespective of surgical approach.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Lehtinen M, Romary DJ, An S, et al. The Robot Effect: How Surgical Approach Relates to Guideline-Directed Management of Concomitant Diseases During Mitral Valve Repair. Ann Thorac Surg. 2026. PMID: 42617966. doi:10.1016/j.athoracsur.2026.08.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。